Clinical Trials · NCT01093729

A Study of HM11260C in Healthy Male Subject

Name: A Study of HM11260C in Healthy Male Subject
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 1Exenatide

Phase: Phase 1
Recruitment status: Completed
Sponsor: Hanmi Pharmaceutical Company Limited
Enrollment: 41
Start date: Feb 2010
Locations: See registry
Primary endpoint: Safety

View Exenatide compound reference